Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PQ912 Drug Interaction Study
NCT02190708Phase 1Completed
- Sponsor
- Vivoryon Therapeutics N.V.
- Start
- Jun 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of varoglutamstat in Alzheimer's disease (AD), sponsored by Vivoryon Therapeutics N.V. Primary endpoints: Pharmacokinetic profile of Omeprazole at Day 6 and Pharmacokinetic profile of Midazolam at Day 6. Started Jun 2014; status: completed.
02
Drugs
varoglutamstat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02190708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02190708.